|
1
|
Allemani C, Weir HK, Carreira H, Harewood
R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A,
et al: Global surveillance of cancer survival 1995–2009: Analysis
of individual data for 25,676,887 patients from 279
population-based registries in 67 countries (CONCORD-2). Lancet.
385:977–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spolverato G, Ejaz A, Kim Y, Squires MH,
Poultsides GA, Fields RC, Schmidt C, Weber SM, Votanopoulos K,
Maithel SK and Pawlik TM: Rates and patterns of recurrence after
curative intent resection for gastric cancer: A United States
multi-institutional analysis. J Am Coll Surg. 219:664–675. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
In H, Solsky I, Palis B, Langdon-Embry M,
Ajani J and Sano T: Validation of the 8th edition of the AJCC TNM
staging system for gastric cancer using the national cancer
database. Ann Surg Oncol. 24:3683–3691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Borrmann R: Geschwulste des magens und des
duodenums. Handbuch spez pathol anat und histo. Henke F and
Lubarsch O: Springer Verlag; Berlin: pp. 812–1054. 1926, (In
German).
|
|
6
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fléjou JF: WHO Classification of digestive
tumors: The fourth edition. Ann Pathol. 31:S27–S31. 2011.(In
French). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cristescu R, Lee J, Nebozhyn M, Kim KM,
Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular
analysis of gastric cancer identifies subtypes associated with
distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng H, Takahashi H, Murai Y, Cui Z,
Nomoto K, Miwa S, Tsuneyama K and Takano Y: Pathobiological
characteristics of intestinal and diffuse-type gastric carcinoma in
Japan: An immunostaining study on the tissue microarray. J Clin
Pathol. 60:273–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qiu MZ, Cai MY, Zhang DS, Wang ZQ, Wang
DS, Li YH and Xu RH: Clinicopathological characteristics and
prognostic analysis of Lauren classification in gastric
adenocarcinoma in China. J Transl Med. 11:582013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gong EJ, Lee JY, Bae SE, Park YS, Choi KD,
Song HJ, Lee GH, Jung HY, Jeong WJ, Cheon GJ, et al:
Characteristics of non-cardia gastric cancer with a high serum
anti-Helicobacter pylori IgG titer and its association with
diffuse-type histology. PLoS One. 13:e01952642018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang CT, Zeng L, Yang J, Zeng C and Chen
Y: Analysis of the incidence and survival of gastric cancer based
on the lauren classification: A large population-based study using
SEER. Front Oncol. 10:12122020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pan Q, Shai O, Lee LJ, Frey BJ and
Blencowe BJ: Deep surveying of alternative splicing complexity in
the human transcriptome by high-throughput sequencing. Nat Genet.
40:1413–1415. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang G, Zhang Y and Yang J: Identification
of potentially functional CircRNA-miRNA-mRNA regulatory network in
gastric carcinoma using bioinformatics analysis. Med Sci Monit.
25:8777–8796. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen S, Pan S, Wu H, Zhou J, Huang Y, Wang
S and Liu A: ICAM1 regulates the development of gastric cancer and
may be a potential biomarker for the early diagnosis and prognosis
of gastric cancer. Cancer Manag Res. 12:1523–1534. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li R, Jiang J, Shi H, Qian H, Zhang X and
Xu W: CircRNA: A rising star in gastric cancer. Cell Mol Life Sci.
77:1661–1680. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oh SC, Sohn BH, Cheong JH, Kim SB, Lee JE,
Park KC, Lee SH, Park JL, Park YY, Lee HS, et al: Clinical and
genomic landscape of gastric cancer with a mesenchymal phenotype.
Nat Commun. 9:17772018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wilson CL and Miller CJ: Simpleaffy: A
BioConductor package for Affymetrix quality control and data
analysis. Bioinformatics. 21:3683–3685. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Therneau TM and Grambsch PM: The Cox
model. Modeling Survival Data: Extending the Cox Model. Springer;
Berlin: pp. 39–77. 2000
|
|
23
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45(D1): D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: cytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ooi CH, Ivanova T, Wu J, Lee M, Tan IB,
Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, et al: Oncogenic
pathway combinations predict clinical prognosis in gastric cancer.
PLoS Genet. 5:e10006762009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Muratani M, Deng N, Ooi WF, Lin SJ, Xing
M, Xu C, Qamra A, Tay ST, Malik S, Wu J, et al: Nanoscale chromatin
profiling of gastric adenocarcinoma reveals cancer-associated
cryptic promoters and somatically acquired regulatory elements. Nat
Commun. 5:43612014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qiu M, Zhou Y, Zhang X, Wang Z, Wang F,
Shao J, Lu J, Jin Y, Wei X, Zhang D, et al: Lauren classification
combined with HER2 status is a better prognostic factor in Chinese
gastric cancer patients. BMC Cancer. 14:8232014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen YC, Fang WL, Wang RF, Liu CA, Yang
MH, Lo SS, Wu CW, Li AF, Shyr YM and Huang KH: Clinicopathological
variation of lauren classification in gastric cancer. Pathol Oncol
Res. 22:197–202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Janjigian YY, Werner D, Pauligk C,
Steinmetz K, Kelsen DP, Jäger E, Altmannsberger HM, Robinson E,
Tafe LJ, Tang LH, et al: Prognosis of metastatic gastric and
gastroesophageal junction cancer by HER2 status: A European and USA
international collaborative analysis. Ann Oncol. 23:2656–2662.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu H, Cassis LA, Kooi CW and Daugherty A:
Structure and functions of angiotensinogen. Hypertens Res.
39:492–500. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kobori H, Nangaku M, Navar LG and
Nishiyama A: The intrarenal renin-angiotensin system: From
physiology to the pathobiology of hypertension and kidney disease.
Pharmacol Rev. 59:251–287. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ferrario CM: Role of angiotensin II in
cardiovascular disease therapeutic implications of more than a
century of research. J Renin Angiotensin Aldosterone Syst. 7:3–14.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Paul M, Poyan Mehr A and Kreutz R:
Physiology of local renin-angiotensin systems. Physiol Rev.
86:747–803. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
George AJ, Thomas WG and Hannan RD: The
renin-angiotensin system and cancer: Old dog, new tricks. Nat Rev
Cancer. 10:745–759. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ager EI, Neo J and Christophi C: The
renin-angiotensin system and malignancy. Carcinogenesis.
29:1675–1684. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chauhan VP, Martin JD, Liu H, Lacorre DA,
Jain SR, Kozin SV, Stylianopoulos T, Mousa AS, Han X,
Adstamongkonkul P, et al: Angiotensin inhibition enhances drug
delivery and potentiates chemotherapy by decompressing tumour blood
vessels. Nat Commun. 4:25162013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ji Y, Wang Z, Li Z, Li K, Le X and Zhang
T: Angiotensin II induces angiogenic factors production partly via
AT1/JAK2/STAT3/SOCS3 signaling pathway in MHCC97H cells. Cell
Physiol Biochem. 29:863–874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Anandanadesan R, Gong Q, Chipitsyna G,
Witkiewicz A, Yeo CJ and Arafat HA: Angiotensin II induces vascular
endothelial growth factor in pancreatic cancer cells through an
angiotensin II type 1 receptor and ERK1/2 signaling. J Gastrointest
Surg. 12:57–66. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Murdoch C: CXCR4: Chemokine receptor
extraordinaire. Immunol Rev. 177:175–184. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Balabanian K, Lagane B, Infantino S, Chow
KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M and
Bachelerie F: The chemokine SDF-1/CXCL12 binds to and signals
through the orphan receptor RDC1 in T lymphocytes. J Biol Chem.
280:35760–35766. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ratajczak MZ, Zuba-Surma E, Kucia M, Reca
R, Wojakowski W and Ratajczak J: The pleiotropic effects of the
SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis.
Leukemia. 20:1915–1924. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ma J, Su H, Yu B, Guo T, Gong Z, Qi J,
Zhao X and Du J: CXCL12 gene silencing down-regulates metastatic
potential via blockage of MAPK/PI3K/AP-1 signaling pathway in colon
cancer. Clin Transl Oncol. 20:1035–1045. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liepelt A and Tacke F: Stromal
cell-derived factor-1 (SDF-1) as a target in liver diseases. Am J
Physiol Gastrointest Liver Physiol. 311:G203–G209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ishigami S, Natsugoe S, Okumura H,
Matsumoto M, Nakajo A, Uenosono Y, Arigami T, Uchikado Y, Setoyama
T, Arima H, et al: Clinical implication of CXCL12 expression in
gastric cancer. Ann Surg Oncol. 14:3154–3158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yang-Feng TL, Xue FY, Zhong WW, Cotecchia
S, Frielle T, Caron MG, Lefkowitz RJ and Francke U: Chromosomal
organization of adrenergic receptor genes. Proc Natl Acad Sci USA.
87:1516–1520. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wu FQ, Fang T, Yu LX, Lv GS, Lv HW, Liang
D, Li T, Wang CZ, Tan YX, Ding J, et al: ADRB2 signaling promotes
HCC progression and sorafenib resistance by inhibiting autophagic
degradation of HIF1α. J Hepatol. 65:314–324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen D, Xing W, Hong J, Wang M, Huang Y,
Zhu C, Yuan Y and Zeng W: The beta2-adrenergic receptor is a
potential prognostic biomarker for human hepatocellular carcinoma
after curative resection. Ann Surg Oncol. 19:3556–3565. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zahalka AH, Arnal-Estapé A, Maryanovich M,
Nakahara F, Cruz CD, Finley LWS and Frenette PS: Adrenergic nerves
activate an angio-metabolic switch in prostate cancer. Science.
358:321–326. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang X, Zhang Y, He Z, Yin K, Li B, Zhang
L and Xu Z: Chronic stress promotes gastric cancer progression and
metastasis: An essential role for ADRB2. Cell Death Dis.
10:7882019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhi X, Li B, Li Z, Zhang J, Yu J, Zhang L
and Xu Z: Adrenergic modulation of AMPK-dependent autophagy by
chronic stress enhances cell proliferation and survival in gastric
cancer. Int J Oncol. 54:1625–1638. 2019.PubMed/NCBI
|
